Compare Mutual Funds
Nippon India Pharma Fund
Select a Mutual Fund
Risk
Very High
-
Rating
3.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.85
-
NAV
₹625.01
-
Fund Started
10 May 2004
-
Fund Size
₹9044.23 Cr
-
Exit Load
Exit load of 1% if redeemed within 1 month.
-
1 Year
5.29%
-
3 Year
18.85%
-
5 Year
12.13%
-
Equity
97.64%
-
Cash
2.35%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 12.78% |
Lupin Ltd. | 7.45% |
Dr. Reddy's Laboratories Ltd. | 6.68% |
Cipla Ltd. | 6.15% |
Divi's Laboratories Ltd. | 5.46% |
Apollo Hospitals Enterprise Ltd. | 5.27% |
Mankind Pharma Ltd. | 4.03% |
Sai Life Sciences Ltd. | 3.49% |
Ajanta Pharma Ltd. | 3.46% |
Max Healthcare Institute Ltd. | 3.32% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
-
Launch Date
10 May 2004
-
